Literature DB >> 20738164

Relationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection.

Daniel J Merenstein1, Haihong Hu, Esther Robison, Alexandra M Levine, Ruth Greenblatt, Rebecca Schwartz, Kathleen Weber, Mary Young, Gerald Sharp, Chenglong Liu.   

Abstract

OBJECTIVES: Two of the most pressing public health challenges in the United States are treating human immunodeficiency virus (HIV) infection and illegal substance use. High rates of complementary and alternative medicine (CAM) use have been reported by individuals who suffer from both of these diseases. The goal of this study was to examine the relationship between CAM use and illegal substance use in a cohort of women with HIV or at risk for HIV disease. Based on previous research, it was hypothesized that CAM use may decrease substance use.
DESIGN: This was a longitudinal cohort study.
SUBJECTS: The subjects comprised Women in the Women's Interagency HIV Study. OUTCOME MEASURES: The role of CAM use in illegal substance use was examined. Due to the hierarchical structure of the dataset, logistic regression analysis adjusting for repeated measurements (generalized estimating equation model) was carried out to assess associations of CAM use and illicit drug use.
RESULTS: There were 2176 women included in the analysis. After excluding for marijuana use, CAM use was associated with less drug use (odds ratio 0.82; 95% confidence interval: 0.73, 0.90).
CONCLUSIONS: The results supported our hypothesis that CAM users are more health conscious and thus less likely to use illicit drugs. Future studies should target both specific drugs and CAM modalities to help finalize this association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738164      PMCID: PMC3110837          DOI: 10.1089/acm.2009.0584

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  32 in total

Review 1.  Substance use and HIV disentagling the nexus of risk. Introduction.

Authors:  A O'Leary
Journal:  J Subst Abuse       Date:  2001

2.  Substance use disorders and the risk of HIV infection in gay men.

Authors:  C M Ryan; J Huggins; R Beatty
Journal:  J Stud Alcohol       Date:  1999-01

3.  Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus.

Authors:  Tracey E Wilson; Yolanda Barrón; Mardge Cohen; Jean Richardson; Ruth Greenblatt; Henry S Sacks; Mary Young
Journal:  Clin Infect Dis       Date:  2002-01-09       Impact factor: 9.079

Review 4.  Complementary and alternative medicine for glaucoma.

Authors:  D J Rhee; L J Katz; G L Spaeth; J S Myers
Journal:  Surv Ophthalmol       Date:  2001 Jul-Aug       Impact factor: 6.048

5.  Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men.

Authors:  N Jernewall; M C Zea; C A Reisen; P J Poppen
Journal:  AIDS Care       Date:  2005-07

6.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

7.  Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.

Authors:  Farzana Kapadia; David Vlahov; Yingfeng Wu; Mardge H Cohen; Ruth M Greenblatt; Andrea A Howard; Judith A Cook; Lakshmi Goparaju; Elizabeth Golub; Jean Richardson; Tracey E Wilson
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

8.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Authors:  Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients.

Authors:  E Pucci; E Cartechini; C Taus; G Giuliani
Journal:  Eur J Neurol       Date:  2004-04       Impact factor: 6.089

10.  Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

Authors:  John D Morris; Elizabeth T Golub; Shruti H Mehta; Lisa P Jacobson; Stephen J Gange
Journal:  AIDS Res Ther       Date:  2007-06-06       Impact factor: 2.250

View more
  5 in total

Review 1.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

2.  Complementary and Alternative Medicine Use for HIV Management in the State of Florida: Medical Monitoring Project.

Authors:  Natalie E Kelso-Chichetto; Chukwuemeka N Okafor; Jeffrey S Harman; Shantrel S Canidate; Christa L Cook; Robert L Cook
Journal:  J Altern Complement Med       Date:  2016-09-15       Impact factor: 2.579

Review 3.  A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  Stress Management and Relaxation Techniques use among underserved inpatients in an inner city hospital.

Authors:  Paula Gardiner; Ekaterina Sadikova; Amanda C Filippelli; Suzanne Mitchell; Laura F White; Robert Saper; Ted J Kaptchuk; Brian W Jack; Lisa Fredman
Journal:  Complement Ther Med       Date:  2015-03-20       Impact factor: 2.446

5.  Lactobacillus paracasei comparative genomics: towards species pan-genome definition and exploitation of diversity.

Authors:  Tamara Smokvina; Michiel Wels; Justyna Polka; Christian Chervaux; Sylvain Brisse; Jos Boekhorst; Johan E T van Hylckama Vlieg; Roland J Siezen
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.